Feature Channels: Vaccines

• share
• favorite_border

In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose of a COVID-19 vaccine in England, the risk of myocarditis in unvaccinated individuals after COVID-19 infection was at least 11 times higher compared to people who developed myocarditis after receiving a COVID-19 vaccine or booster dose between December 1, 2020 and December 15, 2021, according to new research published today in the American Heart Association’s flagship, peer-reviewed journal Circulation.

• share
• favorite_border

Rutgers Cancer Institute of New Jersey expert shares advice on health and wellness as students transition back into the classroom.

• share
• favorite_border

For the past two-plus years, the COVID-19 pandemic has disrupted children’s education and frustrated parents. Today, with the back-to-school season in full swing, Suzanne Silverstein, MA, ART, founding director of Cedars-Sinai Share & Care, and Rose Bisellach, RN, nurse manager in the Providence Cedars-Sinai Tarzana Medical Center Emergency Room, give their best advice for starting a successful school year.

• share
• favorite_border

Call them “little pinches” or “the thing that gets you a cool Bugs Bunny Band-Aid,” childhood vaccines offer big rewards. A Penn State Health pediatrician offers advice for new parents.

• share
• favorite_border

Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist. This finding offers a new clue in understanding COVID-19’s impact on cardiovascular health.

• share
• favorite_border

Researchers are calling for urgent changes to the GCSE science curriculum to help equip learners with sufficient scientific literacy to be able to identify reliable sources and inform their future vaccination decision-making process.

• share
• favorite_border

• Among US adults with kidney failure receiving dialysis, risk for SARS-CoV-2 infection during the Omicron-dominant period was higher among patients without vaccination and with 1–2 doses compared with 3 doses of mRNA vaccines. • Irrespective of vaccine doses, risk for infection was higher among patients with low circulating levels of anti–SARS-CoV-2 antibodies.

• share
• favorite_border

The claim that the new CDC guidelines prove that the authorized vaccines for COVID-19 do not provide any protection is false.

• share
• favorite_border

Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found.

• share
• favorite_border

As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially Omicron, have developed ways to evade the antibodies we make in response to vaccines.

• share
• favorite_border

The laboratory of Hai-Hui “Howard” Xue at the CDI published the findings of the complex and cascading molecular interactions modulating T-cell immunology in the August issue of the journal Nature Immunology.

• share
• favorite_border

New research from the University of South Australia shows that children’s vaccination and needle fear can be lessened when nurses spend additional time supporting children in the vaccination process.

• share
• favorite_border

A University of Minnesota assistant professor is part of a team that has developed a new way to effectively deliver vaccines through the nose that could lead to better protection against diseases like HIV and COVID-19.

• share
• favorite_border

Chula Veterinary Science joined the World Rabies Day campaign on September 28, to educate and raise awareness about rabies, and organize vaccinations for veterinarian science students who volunteered in the community, while emphasizing that people at risk should be vaccinated regularly against rabies.

• share
• favorite_border

A new poll shows that 61% of people over 50 who have already gotten at least one dose of COVID-19 vaccine are very likely to roll up their sleeves this fall to get an updated booster shot once they become available. That percentage might increase if health care providers specifically recommend the updated vaccine to their patients, the poll suggests.

• share
• favorite_border

Pediatrician recommends these steps parents can take to help their children—and themselves—transition from the swimming pool to the classroom as smoothly as possible.

• share
• favorite_border

The American College of Rheumatology (ACR) released a summary of its new treatment guideline for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases (RMDs). The effectiveness and safety of vaccines may differ in rheumatology patients as compared to the general population.

• share
• favorite_border

Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine.

• share
• favorite_border

• share
• favorite_border

Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.

• share
• favorite_border

A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice.

• share
• favorite_border

New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up the nose has an advantage over a shot.

• share
• favorite_border

The dominant COVID-19 viral variant in the U.S. seems to hold the key to get through former immunities. A Penn State Health infectious disease physician discusses BA.5 and how you can protect yourself.

• share
• favorite_border

Moderna vaccines are better than Pfizer in protecting residents of long-term care (LTC) homes from COVID-19 Omicron infections, say McMaster University researchers.

• share
• favorite_border

Two studies presented today at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how SARS-CoV-2 antibody levels vary among recipients of COVID-19 vaccines and naturally infected individuals. These findings add to a growing body of knowledge that is essential for guiding public health initiatives, and that might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2.

• share
• favorite_border

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

• share
• favorite_border

UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

• share
• favorite_border

Researchers at Texas Biomed have received approval to work with a weakened, non-harmful version of SARS-CoV-2 in biosafety level 2 (BSL-2) laboratories, which makes it safer, faster and easier to study the virus, its mutations, and to identify new treatments for COVID-19.

• share
• favorite_border

A novel long-term study of how vaccine-related fears influence flu shot outcomes has found that these fears not only reduce vaccination, but also fuel symptoms of dizziness and lightheadedness at the time of the injection.

• share
• favorite_border

Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [July 20], found protection in older adults aged over 65 years, and in clinically vulnerable adults.